alxn1840
Showing 1 - 13 of 13
Wilson Disease Trial (ALXN1840)
Available
- Wilson Disease
- ALXN1840
- (no location specified)
Jan 6, 2023
Wilson Disease Trial in London (ALXN1840)
Completed
- Wilson Disease
- ALXN1840
-
London, United KingdomRichmond Pharmacology Ltd., St George's University of London
Nov 29, 2022
Wilson Disease Trial in New Zealand, United Kingdom, United States (ALXN1840)
Completed
- Wilson Disease
- ALXN1840
-
New Haven, Connecticut
- +3 more
Nov 29, 2022
Healthy Trial in Melbourne (ALXN1840)
Completed
- Healthy
- ALXN1840
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd.
Mar 21, 2022
Healthy Trial in London (ALXN1840)
Completed
- Healthy
- ALXN1840
-
London, United KingdomClinical Trial Site
Apr 1, 2022
Wilson Disease Trial in Worldwide (ALXN1840, Standard of Care)
Recruiting
- Wilson Disease
- ALXN1840
- Standard of Care
-
Parkville, Australia
- +18 more
Jun 3, 2022
Wilson Disease Trial in Austin (ALXN1840, Bupropion Hydrochloride)
Completed
- Wilson Disease
- ALXN1840
- Bupropion Hydrochloride
-
Austin, TexasClinical Trial Site
Jul 21, 2021
Healthy Trial in Austin (ALXN1840, Placebo, Moxifloxacin)
Unknown status
- Healthy
- ALXN1840
- +2 more
-
Austin, TexasClinical Research Site
Feb 11, 2021
Healthy Trial in London (ALXN1840)
Completed
- Healthy
- ALXN1840
-
London, United KingdomClinical Study Site
Feb 11, 2021
Wilson Disease Trial in Worldwide (ALXN1840, SoC Therapy)
Active, not recruiting
- Wilson Disease
- ALXN1840
- SoC Therapy
-
Los Angeles, California
- +53 more
May 2, 2022